PDL received Certificate of suitability from the office of European Directorate for the Quality of Medicines & HealthCare, France

PDL received Certificate of suitability from the office of European Directorate for the Quality of Medicines & HealthCare, France Monday July16,2007 The Director of European Directorate for the Quality of Medicines & HealthCare has issued certificate of suitability no.RO-CEP 2005-064-Rev 00 to the Company for its product-Flucloxacillin Sodium.

See also  Minivet, a Mauritius based FII picks up 4.93% stake in PDL

Category: Uncategorized